Literature DB >> 9886983

Paracrine upregulation of VEGF receptor mRNA in endothelial cells by hypoxia-exposed hep G2 cells.

H Suzuki1, K Seto, Y Shinoda, M Mori, Y Ishimura, M Suematsu, H Ishii.   

Abstract

Although vascular endothelial growth factor (VEGF) plays a role in the growth of hypervascular tumors, mechanisms for paracrine regulation of its receptor expression on vascular endothelial cells remain unknown. This study aimed to investigate whether VEGF released from hypoxia-exposed Hep G2 cells alters expression of the two distinct receptors, kinase insert domain-containing receptor (KDR) and fms-like tyrosine kinase 1 (flt-1), in human umbilical venous endothelial cells (HUVEC). Hep G2 cells were cultured in 20% or 1% O2 for 16 h to examine induction of VEGF mRNA and its protein expression. Conditioned medium from Hep G2 cells (CM) was applied to HUVEC under normoxic conditions, and expression of mRNA for the VEGF receptors was determined by RT-PCR. In response to the hypoxic challenge, Hep G2 cells upregulated VEGF mRNA and the release of VEGF. Hypoxia-CM preferentially stimulated the mRNA expression of flt-1 but not that of KDR in HUVEC. When the VEGF release from hypoxia-exposed Hep G2 cells was blocked by its antisense oligodeoxynucleotide, the endothelial flt-1 mRNA upregulation elicited by the hypoxia-CM was still maintained. These results suggest that hypoxia-exposed Hep G2 cells not only produce VEGF but also evolve paracrine induction of flt-1 through VEGF-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886983     DOI: 10.1152/ajpgi.1999.276.1.G92

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Functional expression of a proliferation-related ligand in hepatocellular carcinoma and its implications for neovascularization.

Authors:  Hiroshi Okano; Katsuya Shiraki; Yutaka Yamanaka; Hidekazu Inoue; Tomoyuki Kawakita; Yukiko Saitou; Yumi Yamaguchi; Naoyuki Enokimura; Keiichi Ito; Norihiko Yamamoto; Kazushi Sugimoto; Kazumoto Murata; Takeshi Nakano
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

2.  Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy.

Authors:  Y C Tang; Y Li; G X Qian
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 3.  Vascular endothelial growth factor a inhibition in gastric cancer.

Authors:  Do Joong Park; Nicholas J Thomas; Changhwan Yoon; Sam S Yoon
Journal:  Gastric Cancer       Date:  2014-07-04       Impact factor: 7.370

4.  Cationic polybutyl cyanoacrylate nanoparticles for DNA delivery.

Authors:  Jinghua Duan; Yangde Zhang; Wei Chen; Chengrong Shen; Mingmei Liao; Yifeng Pan; Jiwei Wang; Xingming Deng; Jinfeng Zhao
Journal:  J Biomed Biotechnol       Date:  2009-03-11

5.  Investigating the antiproliferative activity of high affinity DNA aptamer on cancer cells.

Authors:  Harleen Kaur; Jasmine J Li; Boon-Huat Bay; Lin-Yue Lanry Yung
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.